Anti-TIGIT Antibody Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-TIGIT Antibody Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Anti-TIGIT Antibody Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Cell Carcinoma
1.3.3 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-TIGIT Antibody Market Perspective (2017-2028)
2.2 Anti-TIGIT Antibody Growth Trends by Region
2.2.1 Anti-TIGIT Antibody Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-TIGIT Antibody Historic Market Size by Region (2017-2022)
2.2.3 Anti-TIGIT Antibody Forecasted Market Size by Region (2023-2028)
2.3 Anti-TIGIT Antibody Market Dynamics
2.3.1 Anti-TIGIT Antibody Industry Trends
2.3.2 Anti-TIGIT Antibody Market Drivers
2.3.3 Anti-TIGIT Antibody Market Challenges
2.3.4 Anti-TIGIT Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-TIGIT Antibody Players by Revenue
3.1.1 Global Top Anti-TIGIT Antibody Players by Revenue (2017-2022)
3.1.2 Global Anti-TIGIT Antibody Revenue Market Share by Players (2017-2022)
3.2 Global Anti-TIGIT Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-TIGIT Antibody Revenue
3.4 Global Anti-TIGIT Antibody Market Concentration Ratio
3.4.1 Global Anti-TIGIT Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-TIGIT Antibody Revenue in 2021
3.5 Anti-TIGIT Antibody Key Players Head office and Area Served
3.6 Key Players Anti-TIGIT Antibody Product Solution and Service
3.7 Date of Enter into Anti-TIGIT Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-TIGIT Antibody Breakdown Data by Type
4.1 Global Anti-TIGIT Antibody Historic Market Size by Type (2017-2022)
4.2 Global Anti-TIGIT Antibody Forecasted Market Size by Type (2023-2028)
5 Anti-TIGIT Antibody Breakdown Data by Application
5.1 Global Anti-TIGIT Antibody Historic Market Size by Application (2017-2022)
5.2 Global Anti-TIGIT Antibody Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anti-TIGIT Antibody Market Size (2017-2028)
6.2 North America Anti-TIGIT Antibody Market Size by Country (2017-2022)
6.3 North America Anti-TIGIT Antibody Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anti-TIGIT Antibody Market Size (2017-2028)
7.2 Europe Anti-TIGIT Antibody Market Size by Country (2017-2022)
7.3 Europe Anti-TIGIT Antibody Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-TIGIT Antibody Market Size (2017-2028)
8.2 Asia-Pacific Anti-TIGIT Antibody Market Size by Country (2017-2022)
8.3 Asia-Pacific Anti-TIGIT Antibody Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anti-TIGIT Antibody Market Size (2017-2028)
9.2 Latin America Anti-TIGIT Antibody Market Size by Country (2017-2022)
9.3 Latin America Anti-TIGIT Antibody Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-TIGIT Antibody Market Size (2017-2028)
10.2 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2017-2022)
10.3 Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Anti-TIGIT Antibody Introduction
11.1.4 Roche Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Anti-TIGIT Antibody Introduction
11.2.4 Merck Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.2.5 Merck Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Anti-TIGIT Antibody Introduction
11.3.4 AstraZeneca Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.3.5 AstraZeneca Recent Development
11.4 Arcus
11.4.1 Arcus Company Detail
11.4.2 Arcus Business Overview
11.4.3 Arcus Anti-TIGIT Antibody Introduction
11.4.4 Arcus Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.4.5 Arcus Recent Development
11.5 Astellas
11.5.1 Astellas Company Detail
11.5.2 Astellas Business Overview
11.5.3 Astellas Anti-TIGIT Antibody Introduction
11.5.4 Astellas Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.5.5 Astellas Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Detail
11.6.2 BeiGene Business Overview
11.6.3 BeiGene Anti-TIGIT Antibody Introduction
11.6.4 BeiGene Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.6.5 BeiGene Recent Development
11.7 BMS
11.7.1 BMS Company Detail
11.7.2 BMS Business Overview
11.7.3 BMS Anti-TIGIT Antibody Introduction
11.7.4 BMS Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.7.5 BMS Recent Development
11.8 Junshi Biosciences
11.8.1 Junshi Biosciences Company Detail
11.8.2 Junshi Biosciences Business Overview
11.8.3 Junshi Biosciences Anti-TIGIT Antibody Introduction
11.8.4 Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.8.5 Junshi Biosciences Recent Development
11.9 Innovent Biologics
11.9.1 Innovent Biologics Company Detail
11.9.2 Innovent Biologics Business Overview
11.9.3 Innovent Biologics Anti-TIGIT Antibody Introduction
11.9.4 Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.9.5 Innovent Biologics Recent Development
11.10 Mereo BioPharma
11.10.1 Mereo BioPharma Company Detail
11.10.2 Mereo BioPharma Business Overview
11.10.3 Mereo BioPharma Anti-TIGIT Antibody Introduction
11.10.4 Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.10.5 Mereo BioPharma Recent Development
11.11 Seattle Genetics
11.11.1 Seattle Genetics Company Detail
11.11.2 Seattle Genetics Business Overview
11.11.3 Seattle Genetics Anti-TIGIT Antibody Introduction
11.11.4 Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.11.5 Seattle Genetics Recent Development
11.12 Hengrui Medicine
11.12.1 Hengrui Medicine Company Detail
11.12.2 Hengrui Medicine Business Overview
11.12.3 Hengrui Medicine Anti-TIGIT Antibody Introduction
11.12.4 Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.12.5 Hengrui Medicine Recent Development
11.13 Compugen
11.13.1 Compugen Company Detail
11.13.2 Compugen Business Overview
11.13.3 Compugen Anti-TIGIT Antibody Introduction
11.13.4 Compugen Revenue in Anti-TIGIT Antibody Business (2017-2022)
11.13.5 Compugen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-TIGIT Antibody Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Anti-TIGIT Antibody Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Anti-TIGIT Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-TIGIT Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anti-TIGIT Antibody Market Share by Region (2017-2022)
Table 8. Global Anti-TIGIT Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anti-TIGIT Antibody Market Share by Region (2023-2028)
Table 10. Anti-TIGIT Antibody Market Trends
Table 11. Anti-TIGIT Antibody Market Drivers
Table 12. Anti-TIGIT Antibody Market Challenges
Table 13. Anti-TIGIT Antibody Market Restraints
Table 14. Global Anti-TIGIT Antibody Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anti-TIGIT Antibody Market Share by Players (2017-2022)
Table 16. Global Top Anti-TIGIT Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2021)
Table 17. Ranking of Global Top Anti-TIGIT Antibody Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anti-TIGIT Antibody Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-TIGIT Antibody Product Solution and Service
Table 21. Date of Enter into Anti-TIGIT Antibody Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-TIGIT Antibody Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anti-TIGIT Antibody Revenue Market Share by Type (2017-2022)
Table 25. Global Anti-TIGIT Antibody Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anti-TIGIT Antibody Revenue Market Share by Type (2023-2028)
Table 27. Global Anti-TIGIT Antibody Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Anti-TIGIT Antibody Revenue Market Share by Application (2017-2022)
Table 29. Global Anti-TIGIT Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Anti-TIGIT Antibody Revenue Market Share by Application (2023-2028)
Table 31. North America Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Anti-TIGIT Antibody Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Anti-TIGIT Antibody Market Size by Country (2023-2028) & (US$ Million)
Table 41. Roche Company Detail
Table 42. Roche Business Overview
Table 43. Roche Anti-TIGIT Antibody Product
Table 44. Roche Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 45. Roche Recent Development
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Anti-TIGIT Antibody Product
Table 49. Merck Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 50. Merck Recent Development
Table 51. AstraZeneca Company Detail
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Anti-TIGIT Antibody Product
Table 54. AstraZeneca Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 55. AstraZeneca Recent Development
Table 56. Arcus Company Detail
Table 57. Arcus Business Overview
Table 58. Arcus Anti-TIGIT Antibody Product
Table 59. Arcus Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 60. Arcus Recent Development
Table 61. Astellas Company Detail
Table 62. Astellas Business Overview
Table 63. Astellas Anti-TIGIT Antibody Product
Table 64. Astellas Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 65. Astellas Recent Development
Table 66. BeiGene Company Detail
Table 67. BeiGene Business Overview
Table 68. BeiGene Anti-TIGIT Antibody Product
Table 69. BeiGene Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 70. BeiGene Recent Development
Table 71. BMS Company Detail
Table 72. BMS Business Overview
Table 73. BMS Anti-TIGIT Antibody Product
Table 74. BMS Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 75. BMS Recent Development
Table 76. Junshi Biosciences Company Detail
Table 77. Junshi Biosciences Business Overview
Table 78. Junshi Biosciences Anti-TIGIT Antibody Product
Table 79. Junshi Biosciences Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 80. Junshi Biosciences Recent Development
Table 81. Innovent Biologics Company Detail
Table 82. Innovent Biologics Business Overview
Table 83. Innovent Biologics Anti-TIGIT Antibody Product
Table 84. Innovent Biologics Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 85. Innovent Biologics Recent Development
Table 86. Mereo BioPharma Company Detail
Table 87. Mereo BioPharma Business Overview
Table 88. Mereo BioPharma Anti-TIGIT Antibody Product
Table 89. Mereo BioPharma Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 90. Mereo BioPharma Recent Development
Table 91. Seattle Genetics Company Detail
Table 92. Seattle Genetics Business Overview
Table 93. Seattle Genetics Anti-TIGIT AntibodyProduct
Table 94. Seattle Genetics Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 95. Seattle Genetics Recent Development
Table 96. Hengrui Medicine Company Detail
Table 97. Hengrui Medicine Business Overview
Table 98. Hengrui Medicine Anti-TIGIT AntibodyProduct
Table 99. Hengrui Medicine Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 100. Hengrui Medicine Recent Development
Table 101. Compugen Company Detail
Table 102. Compugen Business Overview
Table 103. Compugen Anti-TIGIT AntibodyProduct
Table 104. Compugen Revenue in Anti-TIGIT Antibody Business (2017-2022) & (US$ Million)
Table 105. Compugen Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-TIGIT Antibody Market Share by Type: 2021 VS 2028
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Anti-TIGIT Antibody Market Share by Application in 2021 & 2028
Figure 5. Cell Carcinoma Case Studies
Figure 6. Solid Tumor Case Studies
Figure 7. Anti-TIGIT Antibody Report Years Considered
Figure 8. Global Anti-TIGIT Antibody Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Anti-TIGIT Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Anti-TIGIT Antibody Market Share by Region: 2021 VS 2028
Figure 11. Global Anti-TIGIT Antibody Market Share by Players in 2021
Figure 12. Global Top Anti-TIGIT Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-TIGIT Antibody as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Anti-TIGIT Antibody Revenue in 2021
Figure 14. North America Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Anti-TIGIT Antibody Market Share by Country (2017-2028)
Figure 16. United States Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Anti-TIGIT Antibody Market Share by Country (2017-2028)
Figure 20. Germany Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Anti-TIGIT Antibody Market Share by Region (2017-2028)
Figure 28. China Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Anti-TIGIT Antibody Market Share by Country (2017-2028)
Figure 36. Mexico Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Anti-TIGIT Antibody Market Share by Country (2017-2028)
Figure 40. Turkey Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Anti-TIGIT Antibody Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Roche Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 43. Merck Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 44. AstraZeneca Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 45. Arcus Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 46. Astellas Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 47. BeiGene Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 48. BMS Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 49. Junshi Biosciences Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 50. Innovent Biologics Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 51. Mereo BioPharma Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 52. Seattle Genetics Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 53. Hengrui Medicine Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 54. Compugen Revenue Growth Rate in Anti-TIGIT Antibody Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Industry Market Size
